Biomarkers for Targeted Therapies and Immune Checkpoint Inhibitors in Advanced NSCLC

被引：0
作者：
Wang, Jie [1 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp, Thorac Med Oncol, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Immune checkpoint inhibitors; biomarker; dynamic change; Targeted Therapies;
D O I：
10.1016/j.jtho.2016.11.142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE09.01
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [21] Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors
    Proto, C.
    Chiaruttini, M. V.
    Prelaj, A.
    Lo Russo, G.
    Ferrara, R.
    Manglaviti, S.
    De Toma, A.
    Brambilla, M.
    Occhipinti, M.
    Beninato, T.
    Mazzeo, L.
    Pircher, C.
    Dumitrascu, A. D.
    de Braud, F.
    Segale, M.
    Garassino, M. C.
    Sozzi, G.
    Porcu, L.
    Rulli, E.
    Boeri, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S119 - S120
  • [22] Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment
    Liu, Ze-Long
    Liu, Jing-Hua
    Staiculescu, Daniel
    Chen, Jiang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [23] Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Martin, Spencer D. D.
    Bhuiyan, Ishmam
    Soleimani, Maryam
    Wang, Gang
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [24] Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
    Li, Meng
    Kaili, Denis
    Shi, Lei
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (01) : 19 - 37
  • [25] The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
    Li, Ji
    Wang, Min
    Xu, Shuhui
    Li, Yuying
    Li, Jiatong
    Yu, Jinming
    Zhu, Hui
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?
    Bronte, Giuseppe
    Cosi, Donato Michele
    Magri, Chiara
    Frassoldati, Antonio
    Crino, Lucio
    Calabro, Luana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [27] Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC
    Friedlaender, Alex
    Naidoo, Jarushka
    Banna, Giuseppe Luigi
    Metro, Giulio
    Forde, Patrick
    Addeo, Alfredo
    CANCER TREATMENT REVIEWS, 2022, 104
  • [28] Reduced FEV1 as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors
    Shen, Y.
    Shen, C.
    Chiang, C.
    Huang, H.
    Chou, K.
    Chiu, C.
    Chen, Y.
    Luo, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S940 - S940
  • [29] SWI/SNF family mutations in advanced NSCLC: genetic characteristics and immune checkpoint inhibitors' therapeutic implication
    Pang, L. -L.
    Zhou, H. -Q.
    Zhang, Y. -X.
    Zhuang, W. -T.
    Pang, F.
    Chen, L. -J.
    Liao, J.
    Huang, Y. -H.
    Mao, T. -Q.
    Mai, Z. -H.
    Zhang, L.
    Fang, W. -F.
    ESMO OPEN, 2024, 9 (06)
  • [30] Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability
    Tostes, Katiane
    Siqueira, Alexia Polo
    Reis, Rui Manuel
    Leal, Leticia Ferro
    Arantes, Lidia Maria Rebolho Batista
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
12345